Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS)
- 1 May 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (5) , 1736-1748
- https://doi.org/10.1046/j.1523-1755.2003.00939.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Insertional Mutation of the Collagen Genes Col4a3 and Col4a4 in a Mouse Model of Alport SyndromeGenomics, 1999
- A model of autosomal recessive Alport syndrome in English cocker spaniel dogsKidney International, 1998
- Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.Genes & Development, 1996
- Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome.The Journal of cell biology, 1996
- Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma CellsJournal of Biological Chemistry, 1995
- Regulation of 92-kDa Gelatinase B Activity in the Extracellular Matrix by Tissue KallikreinAnnals of the New York Academy of Sciences, 1994
- Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndromeHuman Molecular Genetics, 1994
- Human progelatinase A can be activated by matrilysinFEBS Letters, 1994
- Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.Stroke, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992